These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11828838

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prevalence and determinants of pharmacy shopping behaviour.
    Buurma H, Bouvy ML, De Smet PA, Floor-Schreudering A, Leufkens HG, Egberts AC.
    J Clin Pharm Ther; 2008 Feb; 33(1):17-23. PubMed ID: 18211612
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Is Parkinson's disease a homogeneous disorder--what is the burden of Parkinson's disease in India.
    Ghosh B, Mishra A, Sengupta P.
    J Indian Med Assoc; 2005 Mar; 103(3):146, 148, 150 passim. PubMed ID: 16173291
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of Parkinson's disease in the L'Aquila district, central Italy.
    Totaro R, Marini C, Pistoia F, Sacco S, Russo T, Carolei A.
    Acta Neurol Scand; 2005 Jul; 112(1):24-8. PubMed ID: 15932352
    [Abstract] [Full Text] [Related]

  • 31. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 32. Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA.
    Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ.
    Chin Med J (Engl); 1991 Nov; 104(11):960-4. PubMed ID: 1800040
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Serum cholesterol levels and the risk of Parkinson's disease.
    de Lau LM, Koudstaal PJ, Hofman A, Breteler MM.
    Am J Epidemiol; 2006 Nov 15; 164(10):998-1002. PubMed ID: 16905642
    [Abstract] [Full Text] [Related]

  • 36. Burden of illness in Parkinson's disease.
    Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G.
    Mov Disord; 2005 Nov 15; 20(11):1449-54. PubMed ID: 16007641
    [Abstract] [Full Text] [Related]

  • 37. [Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease].
    Criado-Alvarez JJ, Romo-Barrientos C, Martínez-Hernández J, González-Solana I.
    Rev Neurol; 1998 Sep 15; 27(157):405-8. PubMed ID: 9774809
    [Abstract] [Full Text] [Related]

  • 38. Treatment of Parkinson's disease in Spain.
    Grandas F, Kulisevsky J.
    Mov Disord; 2003 Jan 15; 18(1):87-9. PubMed ID: 12518304
    [Abstract] [Full Text] [Related]

  • 39. Depressive disorders and anti-parkinson drug treatment: a case register study.
    Brandt-Christensen M, Lopez AG, Nilsson FM, Andersen PK, Kessing LV.
    Acta Psychiatr Scand; 2007 Jun 15; 115(6):466-72. PubMed ID: 17498158
    [Abstract] [Full Text] [Related]

  • 40. Type 2 diabetes and the risk of Parkinson's disease.
    Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J.
    Diabetes Care; 2007 Apr 15; 30(4):842-7. PubMed ID: 17251276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.